San Yie Cao Biotechnology Co., Ltd. ("San Yie Cao Biotech-B") will hold a board meeting on Tuesday, August 27, 2024, to consider and approve the mid-term performance report for the six months ending on June 30, 2024 and its publication. The meeting will also discuss whether to propose an interim dividend. The company is chaired by Dr. Liang Peng and this announcement was issued on August 15, 2024 in Shanghai, China. Board members include executive directors Dr. Liang Peng and Mr. Liang Guo, non-executive directors Dr. Wang Xiaodong, Dr. Donna Marie Ambrosino, Dr. Ralf Leo Clemens, and independent non-executive directors Dr. Wu Xiaobin, Mr. Liao Xiang, Mr. Jeffrey Farrow, and Mr. Thomas Leggett.

San Yie Cao Biotechnology Co., Ltd. ("San Yie Cao Biotech-B") will hold a board meeting on Tuesday, August 27, 2024, to consider and approve the mid-term performance report for the six months ending on June 30, 2024 and its publication. The meeting will also discuss whether to propose an interim dividend. The company is chaired by Dr. Liang Peng and this announcement was issued on August 15, 2024 in Shanghai, China. Board members include executive directors Dr. Liang Peng and Mr. Liang Guo, non-executive directors Dr. Wang Xiaodong, Dr. Donna Marie Ambrosino, Dr. Ralf Leo Clemens, and independent non-executive directors Dr. Wu Xiaobin, Mr. Liao Xiang, Mr. Jeffrey Farrow, and Mr. Thomas Leggett.